Keep Me Logged In
Joe Jimenez, CEO of Novartis, discusses the $5 billion share buyback program. He also says the Novartis pipeline is very strong, with many upcoming blockbuster drugs.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by